India Inc spent $18bn on global buyouts in 2025 and the deal value could cross $15bn in the first half of 2026. In late April, India's Sun Pharmaceuticals agreed to pay $11.75bn (£8.59bn) to acquire New York-listed women's health and biosimilars firm Organon & Co. It marked the biggest overseas acquisition by an Indian company in nearly two decades and followe... [5351 chars]
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
